Clinical Trial Update: Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on total marrow irradiation with autologous stem cell transplantation for relapsed or refractory multiple myeloma (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN